Search results :

Brimonidine

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: S01EA05

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Ocular hyperaemia 7.7% - 24.8% x x x x x x x
Conjunctival hyperaemia 18.2% x x x x x x x
Stinging common — 7.1% - 35.5% x x x x x x x x x x x x x
Drowsiness very common, 1% - 15.2% x x x x x x x x x
Fatigue very common, 1% - 15.2% x x x x x x x x x x x x x x x
Hyperaemia common, very common x
Headache very common, 2.4% - 17% x x x x x x x x x x x x x x x x
Conjunctivitis allergic common, 9.2% x x x x x x x
Dry mouth very common, 1% - 21% x x x x x x x x x x x x x x x x
Sensation of foreign body common — 0% - 15.5% x x x x x x x x x x x x x x x
Pruritus postmarketing — 1% - 9.8% x x x x x x x x x x x
Eye pruritus common, 8.2% x x x x x x
Vision blurred 0% - 18% x x x x x x x x x x x x x x x
Corneal staining 4.1% - 9.2% x x x x x
Conjunctival follicles very common, 1% - 8.5% x x x x x x
Visual disturbance common, 6.1% x x x x x x x
Burning sensation in eye 5.3% x
Oedema common x
Nasopharyngitis 5% x
Rosacea 5% x
Conjunctival oedema common, 1.3% - 6.3% x x x x x x x x x x x x x x
Lacrimation common x x x x x x x x x x x x x
Gastrointestinal symptom NOS common x x x x x x x
Pain 2.6% - 5.1% x x x x x x
Intraocular pressure increased 4% x
Eye pain common, 1.8% x x x x x x x x x
Blepharitis common, 1.6% x x x x x x x x x x x x x x
Photophobia common, 0.5% - 8.4% x x x x x x x x x x x x x x
Eye irritation common — 1.6% x x x x x x x x x x x x x x x
Dry eye common, 2.9% x x x x x x x
Dizziness uncommon, common x x x x x x x x x x x x x x
Flushing 0% - 10% x x
Lacrimation increased common, 2.6% x x x x x x x
Eyelid oedema common, 2.1% x x x x x x x x x x x x x x
Asthenia common, 1.6% x x x x x x x x x x x x x x
Erythema of eyelid 0% - 5.2% x x x x x x x x x x x x
Skin burning sensation 0.604% - 4% x x
Follicular conjunctivitis common, 1.3% x x x x x x x
Punctate keratitis common, 1.3% x x
Eye discharge common, 1.3% x x x x x x x
Rhinitis 1.1% x x x x x x x
Erythema postmarketing — 0.906% - 8% x x x x
Dermatitis 0.302% - 0.909% x x
Dermatitis contact 0.302% - 0.909% x x
Arrhythmia uncommon x x x x
Conjunctivitis uncommon x x x x x x x x
Depression uncommon x
Dysgeusia uncommon x x x x x x
Hypertrophy uncommon x
Palpitations uncommon x x x x x x x
Pharyngitis uncommon x x x x x x
Nasal dryness uncommon x x x x x x x x x x x x
Eye oedema uncommon x
Skin warm 0% - 0.909% x x
Paraesthesia 0.302% - 0.606% x x
Acne 0.302% - 0.606% x
Hypersensitivity postmarketing — 0% - 9.9% x x x x x x x x x x x x x
Nasal congestion 0% - 0.606% x x
Pain of skin 0% - 0.606% x x
Apnoea postmarketing x x x x x x x x x x x x
Coma postmarketing x x
Dyspnoea rare x x x x x x x x x
Rash postmarketing x x x x x x x x
Gastrointestinal disorder rare x x x x x x x
Developmental glaucoma postmarketing x
Hypotension very rare, postmarketing x x x x x x x x x x x x
Body temperature decreased postmarketing x x x x x x x x x x x x
Iritis postmarketing, uncommon x x x x x x x x x x
Keratoconjunctivitis sicca postmarketing x x x
Lethargy postmarketing x x x x x
Miosis postmarketing x x x x x x x x x
Hypotonia postmarketing x x x x x x x x x x x x
Nausea postmarketing x x x x
Pallor postmarketing x x
Syncope very rare, postmarketing x x x x x
Tachycardia postmarketing, uncommon x x x x x x x x x
Vasodilation postmarketing x x x x x x x
Respiratory depression postmarketing x x
Bradycardia postmarketing, uncommon x x x x x x x x x x
Eyelids pruritus postmarketing, uncommon x x x x x
Accidental ingestion postmarketing x
Somnolence postmarketing — 55% x x x x x x x x x x
Hypertension very rare x x x x x x x x
Insomnia very rare x x x x x x x x
Anxiety x x
Arthralgia x x
Arthritis x x
Mental disorder x
Blepharoconjunctivitis x x x x x
Bronchitis x x x x x
Chest pain x x
Common cold x x x
Infection x x x x x
Conjunctival haemorrhage x x x x x x x
Corneal oedema x
Cough x x x x x
Cyanosis x x x x
Diabetes mellitus x x
Dyspepsia x x x x x
Eye disorder x x x x
Eye infection x
Vitreous floaters x x x x x
Cardiac disorder x x
Hordeolum x x x
Hypercholesterolaemia x x x x x
Immune system disorder x x x
Influenza x x x x x
Iridocyclitis x
Arthropathy x x
Keratitis x x x x x
Mediastinal disorder x x
Nervous system disorder x x
Osteoporosis x x
Respiratory tract infection x x x
Scotoma x x x x x
Sinusitis x x x x x
Swelling x
Loss of consciousness x
Anterior uveitis x x
Angiopathy x x x
Vitreous detachment x x x x x
Burning sensation x x x x x
Cataract x x x x x
Dry skin x
Skin irritation x
Vitreous disorder x x x x x
Allergic contact dermatitis x x
Unspecified disorder of skin and subcutaneous tissue x
Scab x x
Myalgia x x
Discomfort x
Eyelid retraction x
Eye redness x
Erythema facial x
Peripheral coldness x
Corneal erosion x x x x x x
Face oedema x
Ocular stinging x x x
Skin discomfort x
Conjunctival discharge x x x x x x
Blanching x x x x x x x x
Superficial punctate keratopathy x x x x x
Rash papular x
Systemic allergic reaction x
Feeling hot x
Hypoventilation x x x
Unspecified visual loss x
Abnormal vision x x x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

BRIMONIDINE

Side effects:17
Source:FDA Structured Product Label

brimonidine / brimonidine tartrate

Side effects:25
Source:EMA

BRIMONIDINE TARTRATE / ALPHAGAN P

Side effects:12
Source:FDA

/ ALPHAGAN P 1.5 Eye Drops

Side effects:36
Source:medicines.org.au

BRIMONIDINE TARTRATE / APO-BRIMONIDINE P

Side effects:38
Source:Health Canada

BRIMONIDINE TARTRATE / SANDOZ BRIMONIDINE

Side effects:26
Source:Health Canada

BRIMONIDINE TARTRATE / APO-BRIMONIDINE

Side effects:38
Source:Health Canada

BRIMONIDINE TARTRATE / RATIO-BRIMONIDINE

Side effects:40
Source:Health Canada

BRIMONIDINE

Side effects:47
Source:FDA Structured Product Label

brimonidine

Side effects:48
Source:FDA Structured Product Label

BRIMONIDINE

Side effects:70
Source:FDA Structured Product Label

BRIMONIDINE TARTRATE / ALPHAGAN P

Side effects:68
Source:FDA

BRIMONIDINE TARTRATE / ALPHAGAN P

Side effects:69
Source:FDA

brimonidine

Side effects:75
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label